Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells

Nanomaterials
Rachel S RileyEmily S Day

Abstract

Light-activated therapies are ideal for treating cancer because they are non-invasive and highly specific to the area of light application. Photothermal therapy (PTT) and photodynamic therapy (PDT) are two types of light-activated therapies that show great promise for treating solid tumors. In PTT, nanoparticles embedded within tumors emit heat in response to laser light that induces cancer cell death. In PDT, photosensitizers introduced to the diseased tissue transfer the absorbed light energy to nearby ground state molecular oxygen to produce singlet oxygen, which is a potent reactive oxygen species (ROS) that is toxic to cancer cells. Although PTT and PDT have been extensively evaluated as independent therapeutic strategies, they each face limitations that hinder their overall success. To overcome these limitations, we evaluated a dual PTT/PDT strategy for treatment of triple negative breast cancer (TNBC) cells mediated by a powerful combination of silica core/gold shell nanoshells (NSs) and palladium 10,10-dimethyl-5,15-bis(pentafluorophenyl)biladiene-based (Pd[DMBil1]-PEG750) photosensitizers (PSs), which enable PTT and PDT, respectively. We found that dual therapy works synergistically to induce more cell death than eithe...Continue Reading

References

May 2, 2003·Nature Reviews. Cancer·Dennis E J G J DolmansRakesh K Jain
Jun 24, 2006·Nature Reviews. Cancer·Ana P CastanoMichael R Hamblin
Oct 13, 2006·The Oncologist·Martijn TriesscheijnFiona A Stewart
Dec 5, 2008·Accounts of Chemical Research·Surbhi LalNaomi J Halas
Jul 31, 2009·Journal of Biomechanical Engineering·Emily S DayJennifer L West
Nov 27, 2010·Journal of Neuro-oncology·Emily S DayJennifer L West
May 28, 2011·CA: a Cancer Journal for Clinicians·Patrizia AgostinisJakub Golab
May 4, 2012·Journal of Pharmacy Practice·Carrie L Griffiths, Jacqueline L Olin
May 16, 2012·Nanomedicine·Emily S DayJennifer L West
Sep 21, 2012·The Journal of Physical Chemistry. C, Nanomaterials and Interfaces·Allen J PistnerJoel Rosenthal
Jan 1, 2011·Cancers·Pawel MrozMichael R Hamblin
May 14, 2014·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Ludmil Benov
Dec 1, 2005·Photodiagnosis and Photodynamic Therapy·Dominika NowisJakub Gołąb
Nov 8, 2014·Photodermatology, Photoimmunology & Photomedicine·Hongfei WangLong Geng
Dec 11, 2014·ACS Nano·Marta Pérez-HernándezJesús M de la Fuente
Jan 21, 2015·Chemical Reviews·Sasidharan Swarnalatha LuckyYong Zhang
Aug 25, 2015·International Journal of Toxicology·Joshua M SternGlenn P Goodrich
Sep 2, 2015·Current Pharmaceutical Design·Josimar O EloyRobert J Lee
Nov 27, 2015·International Journal of Nanomedicine·Brittany L FayEmily S Day
Jun 24, 2016·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·David M OzogGirish S Munavalli
Feb 6, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Rachel S Riley, Emily S Day
May 1, 2015·Chemical Science·Cristina MariGilles Gasser
May 31, 2018·International Journal of Nanomedicine·Essraa A HusseinAhmed A Elzatahry

❮ Previous
Next ❯

Methods Mentioned

BETA
dynamic light scattering
scanning electron microscopy
flow cytometry

Software Mentioned

NovoExpress

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

International Journal of Molecular Sciences
Tilahun Ayane DebeleHsieh-Chih Tsai
Journal of Controlled Release : Official Journal of the Controlled Release Society
Alyssa MasterAnirban Sen Gupta
Lasers in Surgery and Medicine
Viola Heinzelmann-SchwarzDaniel Fink
© 2022 Meta ULC. All rights reserved